| Literature DB >> 7394933 |
Abstract
Sera of patients with prostatic malignancy were assayed for human chorionic gonadotropin-beta (HCG-beta). The levels of HCB-beta are negligible in the patients and in a control group with benign prostatic hypertrophy. Slight increases in HCG-beta found in a small percentage of patients with advanced malignancy are attributed to cross-reacting gonadotropins.Entities:
Mesh:
Substances:
Year: 1980 PMID: 7394933 DOI: 10.1159/000280334
Source DB: PubMed Journal: Urol Int ISSN: 0042-1138 Impact factor: 2.089